TG Therapeutics (TGTX) Plans Conf. Call for GENUINE Phase 3 Update

October 12, 2016 4:31 PM EDT
Get Alerts TGTX Hot Sheet
Trade TGTX Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with's Dividend Insider Elite. Sign-up for a FREE trial here.

TG Therapeutics, Inc. (Nasdaq: TGTX), announced that a conference call will be held tomorrow, Thursday, October 13, 2016 at 8:30am ET to provide an update on the GENUINE Phase 3 Trial. Michael S. Weiss, Executive Chairman and Interim Chief Executive Officer, will host the call.

In order to participate in the conference call, please call 1-877-407-8029 (U.S.), 1-201-689-8029 (outside the U.S.), Conference Title: TG Therapeutics GENUINE Update Call. A live webcast of this presentation will be available on the Events page, located within the Investors & Media section, of the Company's website at An audio recording of the conference call will also be available for replay at, for a period of 30 days after the call.

TG Therapeutics will announce details of the amendments in a press release to be issued prior to the call.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Conference Calls, Corporate News

Related Entities

Definitive Agreement

Add Your Comment